The emergency use authorization (EUA) for a traditional herbal formula developed in Taiwan to treat COVID-19, known as Taiwan Chingguan Yihau (NRICM101), will be extended to June 2024, Health Minister Hsueh Jui-yuan (薛瑞元) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![COVID-19 epidemic phase to pass mid-August: CDC]()
COVID-19 epidemic phase to pass mid-August: CDCAlthough Taiwan is still in a COVID-19 epidemic phase, it is expected to pass by mid-August, said the Centers for Disease Control (CDC) at a press conference in Taipei on Tuesday.07/30/2024 08:01 PM![COVID-19, influenza outbreaks have peaked: CDC]()
COVID-19, influenza outbreaks have peaked: CDCCOVID-19 and influenza cases in Taiwan have peaked, with the epidemic phases likely to pass by mid-August, the Centers for Disease Control (CDC) said Tuesday.07/16/2024 08:45 PM![CDC to buy 5.5 million Moderna JN.1 COVID-19 vaccine shots for October rollout]()
CDC to buy 5.5 million Moderna JN.1 COVID-19 vaccine shots for October rolloutThe Centers for Disease Control (CDC) on Wednesday announced a plan to purchase 5.5 million doses of the Moderna monovalent JN.1 COVID-19 vaccine, which will be administered, along with the flu vaccine, from Oct. 1.07/10/2024 09:40 PM
Latest
- Cross-Strait
Collision between Navy vessel, Chinese fishing boat under investigation
04/04/2025 06:54 PM - Society
Man killed by runaway trackless train at Yilan Green Expo
04/04/2025 06:39 PM - Society
Man gets jail time for stealing winning lottery receipts
04/04/2025 04:59 PM - Culture
Presales open for Guns N' Roses' May 10 concert in Taoyuan
04/04/2025 04:27 PM - Society
Weather bureau forecasts slightly drier plum rain season
04/04/2025 03:38 PM